FDA.reportPublic FDA data

immunoglobulin G, human 15-18 % per 2 ML Injection

RxCUI
1809032
RxNorm name
immunoglobulin G, human 15-18 % per 2 ML Injection
Display name
immunoglobulin G, human 15-18 % per 2 ML Injection
Full name
immunoglobulin G, human 15-18 % per 2 ML Injection
Term type
SY
Status
DailyMed mapping
Updated
2026-06-04 23:38:59

Purple Book Biologic Products#

BLA, Proprietary name, Proper name table
BLAProprietary nameProper nameLicense typeStatusLatest source
101134Baygam, Gamastan S/DImmune Globulin (Human)351(a)Rx2026-09-01

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
561f48de-2697-4a35-8233-bd1cdb73438fimmunoglobulin G, human 15-18 % in 2 ML Injection [PSN] · 2 ML immunoglobulin G, human 180 MG/ML Injection [SCD] · immunoglobulin G, human 15-18 % per 2 ML Injection [SY]336These highlights do not include all the information needed to use GAMASTAN safely and effectively. See full prescribing information for GAMASTAN. GAMASTAN[immune globulin (human)], solution for intramuscular injection Initial U.S. Approval: 194420240920